| 股號 / 名稱 | 總負債 | 淨值 |
| OLMA Olema Pharmaceuticals Inc | 1,408,184,421.97 | 9,629,707,807.03 |
| COGT Cogent Biosciences Inc | 3,866,721,280.92 | 9,472,369,465.3 |
| RYTM Rhythm Pharmaceuticals Inc | 6,613,941,426.9 | 9,260,006,548.25 |
| PRTA Prothena Corporation PLC | 1,805,100,453.64 | 9,238,272,310.75 |
| MIRM Mirum Pharmaceuticals Inc | 15,441,612,026.18 | 9,146,105,364.15 |
| GHRS GH Research PLC | 332,746,791.58 | 9,125,780,407.19 |
| TERN Terns Pharmaceuticals Inc | 550,715,513.41 | 8,896,192,950.34 |
| TYRA Tyra Biosciences Inc | 668,374,778.91 | 8,784,797,153.85 |
| SEER Seer Inc | 1,152,290,395.24 | 8,512,492,838.29 |
| AUTL Autolus Therapeutics PLC | 12,417,170,741.46 | 8,313,251,888.83 |
| KMDA Kamada Ltd | 3,506,853,668.49 | 8,306,362,072.91 |
| IMNM Immunome Inc | 1,110,450,422.2 | 8,265,242,398.81 |
| REPL Replimune Group Inc | 3,949,555,658.68 | 8,246,984,386.62 |
| ZNTL Zentalis Pharmaceuticals Inc | 2,329,258,858.41 | 7,919,342,322.29 |
| GERN Geron Corp | 9,980,054,946.56 | 7,788,842,945.3 |
| GLUE Monte Rosa Therapeutics Inc | 6,702,037,118.64 | 7,698,962,164.89 |
| MRVI Maravai LifeSciences Holdings Inc | 18,907,784,463.4 | 7,686,623,130.92 |
| SRRK Scholar Rock Holding Corp | 5,221,321,725.44 | 7,672,592,960.32 |
| KURA Kura Oncology Inc | 12,741,117,359.07 | 7,595,771,512.82 |
| MDXG MiMedx Group Inc | 2,506,702,935.69 | 7,483,154,339.88 |
| FATE Fate Therapeutics Inc | 3,432,537,608.59 | 7,330,325,695.84 |
| ALNY Alnylam Pharmaceuticals Inc | 144,616,234,001.56 | 7,324,939,112.48 |
| ATXS Astria Therapeutics Inc | 1,209,256,645.96 | 7,304,864,694.28 |
| FOLD Amicus Therapeutics Inc | 19,992,585,979.97 | 7,216,267,925.02 |
| QURE Uniqure NV | 20,658,048,245.79 | 7,163,717,419.96 |
| IMRX Immuneering Corp | 409,625,549.83 | 7,139,616,530.7 |
| ARCT Arcturus Therapeutics Holdings Inc | 1,809,641,468.68 | 7,032,591,696.07 |
| VYGR Voyager Therapeutics Inc | 2,144,799,695.83 | 6,884,335,384.41 |
| SLDB Solid Biosciences Inc | 1,752,706,535.31 | 6,825,552,727.68 |
| ABSI Absci Corp | 1,085,208,642.06 | 6,587,290,366.23 |
| CMPX Compass Therapeutics Inc. | 677,895,251.82 | 6,564,522,656.35 |
| ADPT Adaptive Biotechnologies Corp | 8,962,241,231.13 | 6,402,361,443.47 |
| PLRX Pliant Therapeutics Inc | 2,389,325,526.3 | 6,273,052,125.6 |
| EYPT EyePoint Pharmaceuticals Inc | 1,613,250,397.62 | 6,269,168,774.81 |
| DSGN Design Therapeutics Inc | 377,374,008.33 | 6,254,700,161.37 |
| FULC Fulcrum Therapeutics Inc | 516,485,655.22 | 6,212,296,476.12 |
| SANA Sana Biotechnology Inc | 7,520,046,172.39 | 6,116,528,034.84 |
| VTYX Ventyx Biosciences Inc | 629,509,953.65 | 5,993,012,425.8 |
| TRVI Trevi Therapeutics Inc | 299,644,357.82 | 5,943,656,289.94 |
| MXCT MaxCyte Inc | 1,039,767,174.33 | 5,645,734,386.1 |
| ABEO Abeona Therapeutics Inc | 1,874,718,911.78 | 5,362,562,951.8 |
| NAUT Nautilus Biotechnology Inc | 995,139,957.58 | 5,296,984,431.18 |
| XBIT XBiotech Inc | 167,359,892.16 | 5,232,502,017.64 |
| SABS SAB Biotherapeutics Inc | 575,425,525.03 | 5,169,690,384.46 |
| RGNX Regenxbio Inc | 11,391,715,593.83 | 5,056,247,999.47 |
| ANNX Annexon Inc | 2,120,184,262.59 | 5,055,934,826.02 |
| TNGX Tango Therapeutics Inc | 1,569,155,575.73 | 5,011,746,052.1 |
| ARQT Arcutis Biotherapeutics Inc | 6,667,588,039.04 | 4,950,426,690.41 |
| AURA Aura Biosciences Inc | 1,044,652,680.17 | 4,906,394,503.22 |
| CCCC C4 Therapeutics Inc | 3,478,730,692.6 | 4,835,648,620.66 |
| RAPT RAPT Therapeutics Inc | 430,989,303.13 | 4,759,516,154.74 |
| RZLT Rezolute Inc | 360,024,199.15 | 4,608,911,042.21 |
| TCRX TScan Therapeutics Inc | 3,701,835,459.02 | 4,510,355,357.21 |
| CRBU Caribou Biosciences Inc | 1,664,172,400.74 | 4,442,208,814.29 |
| MNPR Monopar Therapeutics Inc | 82,659,940.15 | 4,433,216,038.65 |
| CABA Cabaletta Bio Inc | 1,575,043,236.61 | 4,367,704,850.32 |
| WVE WAVE Life Sciences Ltd | 3,412,181,334.28 | 4,147,136,788.85 |
| MNMD Mind Medicine (MindMed) Inc | 3,329,660,129.97 | 4,089,919,999.37 |
| TIL Instil Bio Inc | 2,860,714,204.59 | 3,771,297,330.43 |
| LXRX Lexicon Pharmaceuticals Inc | 2,686,026,053.68 | 3,763,060,868.67 |
| MOLN Molecular Partners AG | 653,884,249.6 | 3,758,191,954.76 |
| CELC Celcuity Inc | 11,244,210,898.46 | 3,662,970,633.76 |
| CBIO Crescent Biopharma Inc | 677,331,539.61 | 3,652,886,448.64 |
| SNDX Syndax Pharmaceuticals Inc | 13,665,699,338.16 | 3,614,961,143.74 |
| PBYI Puma Biotechnology Inc | 2,743,211,525.81 | 3,609,887,733.83 |
| RPTX Repare Therapeutics Inc | 363,907,549.95 | 3,605,471,988.18 |
| ACET Adicet Bio Inc | 981,391,643.09 | 3,418,037,677.81 |
| XOMA Xoma Royalty Corp | 4,860,264,053.9 | 3,380,926,623.88 |
| CTMX CytomX Therapeutics Inc | 1,592,956,758.0 | 3,363,138,371.87 |
| CLLS Cellectis SA | 7,596,554,446.45 | 3,146,704,199.95 |
| TENX Tenax Therapeutics Inc | 206,663,160.25 | 3,013,073,088.45 |
| AVXL Anavex Life Sciences Corp | 280,164,969.18 | 2,971,045,211.34 |
| IMMP Immutep Ltd | 275,098,805.68 | 2,960,271,858.68 |
| BNTC Benitec Biopharma Inc | 76,038,513.88 | 2,931,272,183.08 |
| STTK Shattuck Labs Inc | 222,133,928.72 | 2,920,029,256.19 |
| ABOS Acumen Pharmaceuticals Inc | 1,536,053,141.97 | 2,917,930,994.07 |
| ELDN Eledon Pharmaceuticals Inc | 1,215,206,941.53 | 2,851,569,539.82 |
| CHRS Coherus Oncology Inc | 13,427,155,120.61 | 2,748,848,647.93 |
| FBRX Forte Biosciences Inc | 406,874,947.41 | 2,633,694,770.03 |
| CAPR Capricor Therapeutics Inc | 1,333,209,131.96 | 2,626,499,923.17 |
| KZR Kezar Life Sciences Inc | 461,930,840.08 | 2,598,588,026.19 |
| TNYA Tenaya Therapeutics Inc | 692,489,134.63 | 2,595,205,752.92 |
| CADL Candel Therapeutics Inc | 421,969,907.74 | 2,509,270,957.99 |
| ACIU AC Immune SA | 4,294,565,088.7 | 2,456,599,968.84 |
| ABUS Arbutus Biopharma Corp | 636,086,596.12 | 2,423,931,192.62 |
| AXSM Axsome Therapeutics Inc | 18,650,199,300.03 | 2,308,933,901.45 |
| TVTX Travere Therapeutics Inc | 14,563,097,861.72 | 2,303,829,174.2 |
| TKNO Alpha Teknova Inc | 1,095,324,144.52 | 2,275,205,120.79 |
| ALGS Aligos Therapeutics Inc | 1,187,898,216.61 | 2,249,618,849.85 |
| CRVS Corvus Pharmaceuticals Inc | 272,648,806.35 | 2,247,583,222.42 |
| VTVT vTv Therapeutics Inc | 906,668,457.7 | 2,209,219,474.68 |
| MGNX MacroGenics Inc | 6,381,284,870.23 | 2,098,293,438.38 |
| PRQR ProQR Therapeutics NV | 2,472,695,907.94 | 2,097,553,853.59 |
| VTGN Vistagen Therapeutics Inc | 456,920,064.86 | 2,077,561,355.93 |
| RLYB Rallybio Corp | 144,905,355.73 | 1,974,057,530.4 |
| XFOR X4 Pharmaceuticals Inc | 3,192,364,889.09 | 1,929,743,487.1 |
| ALEC Alector Inc | 8,692,849,428.67 | 1,807,386,619.83 |
| IBIO iBio Inc | 254,171,572.75 | 1,754,992,701.5 |
| FBIO Fortress Biotech Inc | 3,931,736,089.32 | 1,749,449,531.42 |
| IFRX InflaRx NV | 727,358,801.76 | 1,667,385,329.08 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例